ClinicalTrials.gg
CompletedNCT03467737Updated Mar 16, 2018

Assessment of Starch Digestibility and Amylase Sufficiency in Children

An interventional study of Normal sorghum porridge, algal starch and Normal sorghum porridge, algal dextrins in Malnutrition, Child, sponsored by Purdue University. Completed. Open to participants aged 18 Months to 30 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-03-16.

Sponsored by Purdue University · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 5 years 3 months after the study started (first participant enrolled Dec 2012, registered Mar 2018).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
54
Allocation
Randomized
Ages
18 Months to 30 Months
Sex
All
01

Study summary

Research has demonstrated that there is a relationship between malnourishment and insufficient production of pancreatic enzymes, such as α-amylase which digests starch into glucose. Starchy foods that can be easily digested into glucose are critical to the development child for energy and proper growth. This study investigated the use of a noninvasive breath test for the assessment of amylase sufficiency, digestibility of normal and modified sorghum porridges and gastric emptying rate of a sorghum porridge in Malian and U.S. children.

Read the detailed description

The purpose of this research is to test the hypotheses that: 1.) Moderately malnourished stunted children have low pancreatic α-amylase activity; and 2.) Modified starchy food preparations will have better (higher) digestibility than the commonly given foods for both moderately malnourished stunted and healthy non-stunted children. A noninvasive breath test was used to assess amylase insufficiency in moderately malnourished and stunted children in Mali, as well as in healthy children in Mali and the United States. Moderately malnourished and healthy children in Mali were fed sorghum porridges, which are commonly consumed in Mali. Porridges contained a 13C-labeled substrate (algal starch or octanoic acid) for assessment of amylase insufficiency and gastric emptying rate. In a follow-up study, healthy children in the United States were also assessed for amylase sufficiency.

02

Conditions studied

  • Malnutrition, Child
03

In context

Child Nutrition Disorders

168 studies on the registry are indexed under Child Nutrition Disorders; 35 are open to participants now.

This study's enrollment of 54 is below the median of 400 across 133 interventional studies indexed under Child Nutrition Disorders.

Browse Child Nutrition Disorders studies →

Lead sponsor

Purdue University is the lead sponsor of 175 studies on the registry; 21 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Months to 30 Months
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Stunted weaned children in the age range 18 - 30 months with height-for-age Z-score (HAZ) below -2 (HAZ\<-2)
  • Healthy, weaned children 18-30 months of age for study 1
  • Healthy, weaned children up to 5 years old

Exclusion criteria

Exclusion Criteria:

  • Acutely ill and wasted child with weight for height lower than -2 z-score
  • No medical problems other than their malnutrition status
  • No medications
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
54 participants (actual)

Study arms

  • Experimental
    Normal sorghum porridge, algal starch

    Sorghum porridge with 13C-algal starch

    Other: Normal sorghum porridge, algal starch

  • Experimental
    Normal sorghum porridge, algal dextrins

    Sorghum porridge with 13C-algal starch limit dextrins

    Other: Normal sorghum porridge, algal dextrins

  • Experimental
    Normal sorghum porridge, labeled flour

    Sorghum porridge with 13C-labeled sorghum flour

    Other: Normal sorghum porridge, labeled flour

  • Experimental
    Modified sorghum porridge, labeled flour

    Modified sorghum porridge with 13C-labeled sorghum flour

    Other: Modified sorghum porridge, labeled flour

  • Experimental
    Thinned sorghum porridge, labeled flour

    Modified thinned sorghum porridge with 13C-labeled sorghum flour

    Other: Thinned sorghum porridge, labeled flour

  • Experimental
    Modified sorghum porridge, octanoic acid

    Modified sorghum porridge with 13C-labeled octanoic acid

    Other: Modified sorghum porridge, octanoic acid

Interventions

  • OtherNormal sorghum porridge, algal starch

    Normal sorghum porridge with 13C-labeled algal starch was fed, breath tested, as the first arm of an alpha-amylase sufficiency assessment in healthy and moderately malnourished children.

  • OtherNormal sorghum porridge, algal dextrins

    Normal sorghum porridge with 13C-labeled starch limit dextrins was fed, breath tested, as the second arm of an alpha-amylase sufficiency assessment in healthy and moderately malnourished children.

  • OtherNormal sorghum porridge, labeled flour

    Normal sorghum porridge with a portion of 13C-labeled sorghum flour was fed, breath tested, for starch digestibility assessment in healthy and moderately malnourished children.

  • OtherModified sorghum porridge, labeled flour

    Modified sorghum porridge with shear stirring to reduce viscosity with a portion of 13C-labeled sorghum flour was fed, breath tested, for starch digestibility assessment in healthy and moderately malnourished children.

  • OtherThinned sorghum porridge, labeled flour

    Thinned sorghum porridge treated with an alpha-amylase liquifying enzyme with a portion of 13C-labeled sorghum flour was fed, breath tested, for starch digestibility assessment in healthy and moderately malnourished children.

  • OtherModified sorghum porridge, octanoic acid

    Modified sorghum porridge with shear stirring to reduce viscosity with addition of 13C-labeled octanoic acid was fed, breath tested, for gastric emptying assessment in healthy and moderately malnourished children.

06

What researchers measure

Primary outcomes

  1. Alpha-amylase sufficiency in children

    Breath test using 13C-tracer was used to assess alpha-amylase sufficiency in healthy and moderately malnourished children

    Time frame: 3 hours after being fed test meal

  2. Starch digestibility

    Breath test using 13C-tracer in labeled sorghum flour was used to assess starch digestibility of three different prepared sorghum porridges of different thicknesses in healthy and moderately malnourished children

    Time frame: 3 hours after being fed test meal

  3. Gastric emptying

    Breath test using 13C-tracer in octanoic acid was used to assess gastric emptying in healthy and moderately malnourished children

    Time frame: 3 hours after being fed test meal

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No — Not shared

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Dec 2012 to primary completion in Dec 2014, 24 months.

Of 82 non-industry interventional studies with no phase under Child Nutrition Disorders, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 35. This study's 24 months is above that.

Counting every sponsor, half of 85 studies reached it within 19 months; a quarter within 11 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 10, 2018
First posted
Mar 16, 2018
StartActual
Dec 1, 2012
Primary completionActual
Dec 31, 2014
CompletionActual
Jul 1, 2016
Last update
Mar 16, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 16, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03467737
Lead sponsor
Purdue University
Responsible party
Bruce R. Hamaker (Professor, Purdue University) — Principal investigator
First posted
Mar 16, 2018
Start date
Dec 1, 2012
Primary completion
Dec 31, 2014
Completion
Jul 1, 2016
Last update
Mar 16, 2018

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion